BACKGROUND Kommerell’s diverticulum(KD)with aberrant left subclavian artery is a rare congenital deformity and also has very little research literature about it(35%of case study).There are three types of aortic arch ...BACKGROUND Kommerell’s diverticulum(KD)with aberrant left subclavian artery is a rare congenital deformity and also has very little research literature about it(35%of case study).There are three types of aortic arch diverticulum.Even literature concerning the treatment options are limited.CASE SUMMARY We present a case report of a 50-year-old male with KD in the right aortic arch with aberrant left subclavian artery.We conducted a total endovascular repair procedure,which is innovative and will spread more light in the medical world.Our patient has no past medical history and is a non-smoker and non-alcoholic.Patient presented with shortness of breath,chest pain and dizziness for six months.Blood tests were done and computerized tomography(CT)angiogram of the chest confirmed the diagnosis,illustrating showed a 3.9 cm KD.On Day 1,the CT angiogram showed mild dilatation of the thoracic aorta,adjacent esophagus,trachea was compressed and displaced.Surgery was planned as the treatment modality.Carotid-Subclavian artery bypass and endovascular aortic repair was conducted.We used prolene 5-0 C1 sutures to precisely anastomose a 6-mm Dacron graft to the left subclavian artery.Haemostasis was secured and wounds were closed.Protamine was administered and patient was shifted to intensive care unit.Post-operative,patient responded favorably and was discharged.Regular follow-up is done.CONCLUSION The procedure we performed is novel.This will help the cardio-thoracic surgeons a better insight about the full procedures we conducted,thereby bringing more light and better treatment options in managing KD with aberrant subclavian artery.展开更多
目的探讨美罗培南治疗新生儿耐碳青霉烯类肺炎克雷伯菌(CRKP)败血症的疗效及其影响因素,为临床合理使用抗生素提供参考依据。方法采用回顾性研究方法,收集2014年6月至2018年6月在上海交通大学附属儿童医院新生儿科住院的27例CRKP败血症...目的探讨美罗培南治疗新生儿耐碳青霉烯类肺炎克雷伯菌(CRKP)败血症的疗效及其影响因素,为临床合理使用抗生素提供参考依据。方法采用回顾性研究方法,收集2014年6月至2018年6月在上海交通大学附属儿童医院新生儿科住院的27例CRKP败血症患儿的临床资料,分析美罗培南在27例患儿中的治疗效果。根据治疗效果将患儿分为美罗培南单药治疗有效组和美罗培南单药治疗无效需联合治疗组,比较两组患儿围产因素、感染CRKP前接受碳青酶烯类抗生素暴露等临床特点的差异。结果美罗培南单药治疗新生儿CRKP败血症有效率为48.1%(13/27),采用联合治疗后总体有效率为74.1%(20/27)。美罗培南单药治疗无效需联合治疗组患儿存在外科手术后开放性伤口(7/14 vs 1/13)、感染性休克(7/14 vs 1/13)、无菌体腔液(脑脊液及腹水)培养阳性(6/14 vs 0/13)、感染时需有创机械通气(10/14 vs 1/13)的患儿比例高于单药治疗有效组(P均<0.05),纸片扩散法药物敏感性试验中美罗培南抑菌圈直径小于单药治疗有效组[(9.14±3.37) mm vs (12.85±5.27) mm,P<0.05]。结论美罗培南单药治疗新生儿CRKP败血症具有一定疗效。当CRKP败血症患儿存在外科手术后开放性伤口、感染性休克、无菌体腔液培养阳性、感染时需有创机械通气及药物敏感性试验中美罗培南抑菌圈直径偏小时需联合治疗,以提高治疗有效率。展开更多
文摘BACKGROUND Kommerell’s diverticulum(KD)with aberrant left subclavian artery is a rare congenital deformity and also has very little research literature about it(35%of case study).There are three types of aortic arch diverticulum.Even literature concerning the treatment options are limited.CASE SUMMARY We present a case report of a 50-year-old male with KD in the right aortic arch with aberrant left subclavian artery.We conducted a total endovascular repair procedure,which is innovative and will spread more light in the medical world.Our patient has no past medical history and is a non-smoker and non-alcoholic.Patient presented with shortness of breath,chest pain and dizziness for six months.Blood tests were done and computerized tomography(CT)angiogram of the chest confirmed the diagnosis,illustrating showed a 3.9 cm KD.On Day 1,the CT angiogram showed mild dilatation of the thoracic aorta,adjacent esophagus,trachea was compressed and displaced.Surgery was planned as the treatment modality.Carotid-Subclavian artery bypass and endovascular aortic repair was conducted.We used prolene 5-0 C1 sutures to precisely anastomose a 6-mm Dacron graft to the left subclavian artery.Haemostasis was secured and wounds were closed.Protamine was administered and patient was shifted to intensive care unit.Post-operative,patient responded favorably and was discharged.Regular follow-up is done.CONCLUSION The procedure we performed is novel.This will help the cardio-thoracic surgeons a better insight about the full procedures we conducted,thereby bringing more light and better treatment options in managing KD with aberrant subclavian artery.
文摘目的探讨美罗培南治疗新生儿耐碳青霉烯类肺炎克雷伯菌(CRKP)败血症的疗效及其影响因素,为临床合理使用抗生素提供参考依据。方法采用回顾性研究方法,收集2014年6月至2018年6月在上海交通大学附属儿童医院新生儿科住院的27例CRKP败血症患儿的临床资料,分析美罗培南在27例患儿中的治疗效果。根据治疗效果将患儿分为美罗培南单药治疗有效组和美罗培南单药治疗无效需联合治疗组,比较两组患儿围产因素、感染CRKP前接受碳青酶烯类抗生素暴露等临床特点的差异。结果美罗培南单药治疗新生儿CRKP败血症有效率为48.1%(13/27),采用联合治疗后总体有效率为74.1%(20/27)。美罗培南单药治疗无效需联合治疗组患儿存在外科手术后开放性伤口(7/14 vs 1/13)、感染性休克(7/14 vs 1/13)、无菌体腔液(脑脊液及腹水)培养阳性(6/14 vs 0/13)、感染时需有创机械通气(10/14 vs 1/13)的患儿比例高于单药治疗有效组(P均<0.05),纸片扩散法药物敏感性试验中美罗培南抑菌圈直径小于单药治疗有效组[(9.14±3.37) mm vs (12.85±5.27) mm,P<0.05]。结论美罗培南单药治疗新生儿CRKP败血症具有一定疗效。当CRKP败血症患儿存在外科手术后开放性伤口、感染性休克、无菌体腔液培养阳性、感染时需有创机械通气及药物敏感性试验中美罗培南抑菌圈直径偏小时需联合治疗,以提高治疗有效率。
